Vascular dementia

$44 Million NIH Grant to See if Dementia Can Be Prevented

Retrieved on: 
星期二, 四月 6, 2021
Psychiatric diagnosis, Cognitive disorders, Learning disabilities, Psychiatry, Mind, Aging-associated diseases, Psychology, Neuropsychology, Dementia, Brain training, Dementia with Lewy bodies, Vascular dementia

This new grant furthers prior research, published as findings of the ACTIVE Study in 2017 , that showed a small amount of cognitive training significantly reduced the risk and incidence of dementia among older adults.

Key Points: 
  • This new grant furthers prior research, published as findings of the ACTIVE Study in 2017 , that showed a small amount of cognitive training significantly reduced the risk and incidence of dementia among older adults.
  • This study addresses the central question that most people have about brain training does training your brain reduce your chances of dementia?
  • Researchers reported an up to 48 percent reduction in dementia incidence among people who asked to complete up to 18 hours of training and an overall 29 percent reduction in dementia risk.
  • Its gratifying to see the NIH going the distance building on the established science of brain training to answer the crucial question of dementia prevention, Dr. Mahncke observed.

SciSparc to Conduct a Phase IIa Clinical Trial in Alzheimer's Patients Using the Company's Proprietary Cannabinoid-Based Treatment

Retrieved on: 
星期三, 二月 17, 2021
Cognitive disorders, Psychiatric diagnosis, Learning disabilities, Psychiatry, Branches of biology, Abnormal psychology, Aphasias, Dementia, Alzheimer's disease, Vascular dementia, Primary progressive aphasia

Alzheimer's disease is the most common type of dementia, accounting for over two-thirds of cases of dementia.

Key Points: 
  • Alzheimer's disease is the most common type of dementia, accounting for over two-thirds of cases of dementia.
  • Alzheimer's disease is a neurodegenerative disease that causes progressive and disabling impairment of cognitive functions including memory, comprehension, language, attention, reasoning and judgment.
  • The current pharmacological treatment of agitation in Alzheimer's disease has an unsatisfactory benefit/risk ratio and often involves using off-label drugs.
  • The Alzheimer's center treats hundreds of patients a year, as inpatients, outpatients and as part of its diagnosis and counseling services.

Rackspace Technology migrates the British Heart Foundation’s online gift shop to VMware

Retrieved on: 
星期一, 十二月 14, 2020
Cognitive disorders, Learning disabilities, Psychiatric diagnosis, Psychiatry, Medical specialties, Medicine, British Heart Foundation, Rackspace Technology, Dementia, Vascular dementia, National Heart Foundation of Australia

LONDON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Rackspace Technology (NASDAQ: RXT), the multicloud solutions provider, has extended its work with the British Heart Foundation to provide support to its online gift shop ahead of Christmas.

Key Points: 
  • LONDON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Rackspace Technology (NASDAQ: RXT), the multicloud solutions provider, has extended its work with the British Heart Foundation to provide support to its online gift shop ahead of Christmas.
  • The global pandemic has severely hampered fundraising and retail sales for many charities including the British Heart Foundation (BHF).
  • This piece of work has supported our online shop to continue raising vital funds for heart research.
  • Each year, British Heart Foundation (BHF) shops raisemillionsto help the BHF fund life-saving research into all heart diseases, stroke, vascular dementia and diabetes.

Eisai: Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood

Retrieved on: 
星期一, 十一月 9, 2020
Branches of biology, Psychiatric diagnosis, Cognitive disorders, Learning disabilities, Medicine, Psychiatry, Neuroimaging, Alzheimer's disease, Dementia, Positron emission tomography, Amyloid, Vascular dementia

Of these sufferers, those living with AD are thought to account for more than 60% of those living with dementia.

Key Points: 
  • Of these sufferers, those living with AD are thought to account for more than 60% of those living with dementia.
  • (10)
    Sysmex and Eisai are working to create new diagnostic technologies for the prevention and treatment of dementia.
  • (1) A standardization scale for integration analysis of PET SUVR values as measured by different amyloid PET imaging probes.
  • * This finding was expected to lead to the development of a simple method of diagnosing Alzheimer's disease using blood.

Global Dementia with Diabetes Market 2017-2030: Epidemiology, Pipeline, Drugs, Competitive Intelligence

Retrieved on: 
星期一, 八月 24, 2020
Cognitive disorders, Psychiatry, Psychiatric diagnosis, Dementia, Learning disabilities, Cognition, Abnormal psychology, RTT, Vascular dementia, Alzheimer's disease, SWOT analysis, Lewy body dementia

The report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Dementia with Diabetes market size from 2017 to 2030.

Key Points: 
  • The report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Dementia with Diabetes market size from 2017 to 2030.
  • The report also covers current Dementia with Diabetes treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
  • In US (2017), the estimated cases of type specific dementia for Alzheimer's disease, vascular dementia, Lewy-body dementia, Fronto-temporal dementia, mixed dementia and others are 5,796,827, 1,337,729, 535,092, 89,182, 713,456 and 445,910.
  • The publisher performs competitive and market intelligence analysis of the Dementia with Diabetes market by using various competitive intelligence tools that include-SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc.

Dementia with Diabetes: Market Insights, Epidemiology & Forecast 2030 - ResearchAndMarkets.com

Retrieved on: 
星期四, 八月 20, 2020
Diabetes, Pharmaceutical, Health, Mental health, Cognitive disorders, Psychiatry, Psychiatric diagnosis, Learning disabilities, Abnormal psychology, Cognition, RTT, Dementia, Vascular dementia, Alzheimer's disease, Lewy body dementia

The "Dementia with Diabetes - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dementia with Diabetes - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Dementia with Diabetes market size from 2017 to 2030.
  • The report also covers current Dementia with Diabetes treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
  • In US (2017), the estimated cases of type specific dementia for Alzheimer's disease, vascular dementia, Lewy-body dementia, Fronto-temporal dementia, mixed dementia and others are 5,796,827, 1,337,729, 535,092, 89,182, 713,456 and 445,910.

Heart Health Problems in Your 20s May Affect Brain Health Decades Later

Retrieved on: 
星期四, 二月 27, 2020
Diabetes, Cholestanes, Cholesterol, Sterols, Organ systems, Branches of biology, Health, Prediabetes, Vascular dementia

The study involved 189 people with an average age of 24 who were followed for 30 years as part of a larger study.

Key Points: 
  • The study involved 189 people with an average age of 24 who were followed for 30 years as part of a larger study.
  • Each time, their cardiovascular health was assessed based on five factors: smoking, BMI, blood pressure, total cholesterol and fasting blood glucose level.
  • "More focus on a life course research approach is needed to help us better understand how these vascular risk factors affect brain health as we age," Sorond said.
  • Learn more about brain health at BrainandLife.org , home of the American Academy of Neurology's free patient and caregiver magazine focused on the intersection of neurologic disease and brain health.

Exercise to Improve the Age of Your Arteries

Retrieved on: 
星期二, 一月 21, 2020
Vascular diseases, Angiology, Cardiovascular system, Circulatory system, Vascular disease, Vascular surgery, Vascular dementia

Vascular age is a measure of the age of the arteries and involves arteries both large and small.

Key Points: 
  • Vascular age is a measure of the age of the arteries and involves arteries both large and small.
  • If vascular age is assessed as greater than chronological age, someone may be more at risk of developing vascular disease later in life.
  • Following a diagnosis of vascular disease, physical activity can keep complications at bay and impact both the diseases and vascular age.
  • While not everyone can prepare for and run a marathon, daily exercise has been found to significantly improve vascular health.

Nurish.Me, a leader in highly advanced rejuvenation products, announces the release of the new and enhanced CogniNurish Pro, based on discoveries from the landmark Alzheimer's study and other clinical trials, for even greater efficacy.

Retrieved on: 
星期二, 十二月 10, 2019
Cognitive disorders, Psychiatric diagnosis, Psychiatry, Learning disabilities, RTT, Cognition, Neuroscience, Dementia, Alzheimer's disease, Vascular dementia

Approximately 5.5 million Americans currently suffer from Alzheimer's dementia, which accounts for about 70 percent of total dementia cases.

Key Points: 
  • Approximately 5.5 million Americans currently suffer from Alzheimer's dementia, which accounts for about 70 percent of total dementia cases.
  • Risk of dementia doubles every five years after age 60, rising as high as 50 percent for those over age 85.
  • Some study participants experienced renewed ability to recall people, places and events
    Lewis and his team recruited 34 people for their 12-month study, with a mean age of 79.9 years.
  • We are also enhancing the original formula to make it even better, as we continue uncovering exciting new findings."

Global Alzheimer's Disease Markets, 2019-2034: Changing Landscape of Prescribing Patterns

Retrieved on: 
星期二, 六月 18, 2019
Cognitive disorders, Learning disabilities, Psychiatric diagnosis, Psychiatry, RTT, Branches of biology, Nervous system, Aging-associated diseases, Dementia, Alzheimer's disease, Neurodegeneration, Vascular dementia

DUBLIN, June 18, 2019 /PRNewswire/ -- The "Alzheimer's Disease Market and Forecast Analysis 2034" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 18, 2019 /PRNewswire/ -- The "Alzheimer's Disease Market and Forecast Analysis 2034" report has been added to ResearchAndMarkets.com's offering.
  • Alzheimer's disease is an irreversible, progressive, neurodegenerative, and fatal disease that slowly affects memory, cognition, and function.
  • Alzheimer's disease is the most common cause of dementia among older people.
  • The author's survey sheds light on the changing landscape of prescribing patterns in Alzheimer's disease.